Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-10936833

RESUMO

OBJECTIVE: An understanding of bone cellular biology is a basic necessity to understanding events such as distraction osteogenesis. The goal of this study was to determine the effect of continuous cyclic mechanical stretch as a fundamental event in distraction osteogenesis on the expression of 3 bone growth factors, transforming growth factor-beta 1 (TGF-beta1), insulin-like growth factor 1 (IGF-1), basic fibroblast growth factor (bFGF) and 2 cytokines, interleukin (IL)-1 (IL-1) and 6 (IL-6) in human osteoblast-like cells. MATERIAL AND METHODS: A human osteoblast-like cell line, SaOS-2, capable of forming a ground substance and mineralizing it, was maintained. Cells were transferred to 6-well plates with flexible silicon bottoms grown to confluence and either subjected to tensile stretch for different time intervals or used as the control group. RNA was isolated to conduct Northern blot analysis for the expression of 3 bone growth factors, transforming TGF-beta1, IGF-1, bFGF, and 2 cytokines, IL-1 and IL-6. RESULTS: After 8 hours, mRNA for TGF-beta1 and IGF-1 increased in the experimental group, whereas bFGF decreased but cytokines IL-1 and IL-6 were not affected. At 16 hours, TGF-beta1, IGF-1, and bFGF showed increased levels of mRNA; IL-6 showed a slight increase. After 24 hours, TGF-beta1, IGF-1, bFGF, and IL-6 had increased mRNA levels. IL-1beta did never show significant alterations in mRNA production as compared with the control. CONCLUSION: Tensile stretch on osteoblast-like cells alter local regulation of bone formation, increasing the expression of bone growth factors, whereas catabolic cytokines are unaffected. These findings suggest a direct effect of mechanical strain on osteoblasts and may be the driving factors of bone growth during distraction.


Assuntos
Citocinas/biossíntese , Substâncias de Crescimento/biossíntese , Osteoblastos/metabolismo , Osteogênese por Distração , Northern Blotting , Citocinas/genética , Sondas de DNA , Fator 2 de Crescimento de Fibroblastos/biossíntese , Fator 2 de Crescimento de Fibroblastos/genética , Expressão Gênica , Gliceraldeído-3-Fosfato Desidrogenases/biossíntese , Substâncias de Crescimento/genética , Humanos , Fator de Crescimento Insulin-Like I/biossíntese , Fator de Crescimento Insulin-Like I/genética , Interleucina-1/metabolismo , Interleucina-6/biossíntese , Interleucina-6/genética , RNA Mensageiro/análise , Estresse Mecânico , Resistência à Tração , Fator de Crescimento Transformador beta/biossíntese , Fator de Crescimento Transformador beta/genética , Células Tumorais Cultivadas
2.
Artigo em Inglês | MEDLINE | ID: mdl-10348508

RESUMO

Propofol is a sedative-hypnotic intravenous anesthetic agent that has gained wide use in outpatient oral and maxillofacial surgery since its clinical introduction in 1985. Propofol has several therapeutic advantages that make it an excellent choice for use in all phases of general anesthesia and conscious sedation. It is associated with minimal side effects, a controllable anesthetic state, and rapid recovery. This review of propofol discusses its pharmacologic character, administration, and side effects and presents anesthetic drug interaction information and comparisons.


Assuntos
Anestesia Dentária , Anestésicos Intravenosos , Procedimentos Cirúrgicos Bucais/métodos , Propofol , Procedimentos Cirúrgicos Ambulatórios , Analgesia Controlada pelo Paciente , Período de Recuperação da Anestesia , Anestésicos Intravenosos/administração & dosagem , Anestésicos Intravenosos/farmacocinética , Anestésicos Intravenosos/farmacologia , Humanos , Infusões Intravenosas , Taxa de Depuração Metabólica/efeitos dos fármacos , Propofol/administração & dosagem , Propofol/farmacocinética , Propofol/farmacologia
3.
J Hist Dent ; 47(1): 23-7, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10686908

RESUMO

The life of the American oral surgeon Dr. W. Harry Archer was one that affected and inspired, and sometimes incensed, those who knew him and those who would follow him. His life long devotion to the dental specialty of oral surgery was a driving force that caused dramatic changes in aspects of not only oral surgery but of dentistry as a whole. His excellence in leadership, teaching, research, and writing were among his many accomplishments that firmly place him among the eternal giants of the dental community.


Assuntos
Cirurgia Bucal/história , Anestesia Dentária/história , História do Século XX , Óxido Nitroso , Pennsylvania , Faculdades de Odontologia/história
4.
J Oral Maxillofac Surg ; 56(5): 534-43; discussion 543-4, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9590334

RESUMO

PURPOSE: The goal of this study was to evaluate the presence of the inflammatory cytokines interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) within the superior temporomandibular joint (TMJ) space in patients with internal derangements and to compare these values with the pathologic findings seen arthroscopically. PATIENTS AND METHODS: Thirty patients with symptomatic TMJ dysfunction and clinical and imaging evidence of internal derangements of the TMJ were evaluated. Before entering the superior joint space with the arthroscope, 2 mL sterile saline was injected and, after 30 seconds of equilibration, was aspirated for analysis. The surgeon then performed diagnostic arthroscopy. The degree of synovitis, degeneration, percent condylar roofing, and any pathologic changes, such as perforations, were recorded. The level of total protein in each sample was ascertained, as well as the levels of IL-1 beta, IL-6, and TNF-alpha. RESULTS: Of 30 samples tested, three were discarded because of failure to gain access into the superior joint space. Of the 27 remaining samples, IL-6 showed the closest correlation with the level of acute synovitis demonstrated arthroscopically. Two of the higher IL-6 levels (167 and 324 pg/microg protein) were seen with patients with a significant disc perforation. In patients with a high degree of vascularity, IL-6 was found to be between 0 to 581 pg/microg protein with an average of 80 pg/microg protein and a median value of 43 pg/mg. These values significantly correlated with the degree of vascularity (P < or = .02). This is in comparison with the 10 remaining patients, who showed significantly fewer vascular changes arthroscopically. In these patients, the range of IL-6 was 0 to 35 pg/microg protein, with an average of 19 pg/microg protein and a median value of 14.5 pg/microg. These values significantly correlated with the smaller degree of vascularity (P < or = .02). In seven patients, the role of nonsteroidal antiinflammatory drug (NSAID) use resulted in decreased levels of IL-6, which has been noted in previous studies. In patients with higher rated redundancy of the synovial tissue, the average IL-6 level was 92 pg/microg protein, whereas the median value was 44 pg/microg protein. In patients with little or no redundant synovial tissue, an average IL-6 level of 22 pg/microg protein was present. The median value in these same joints was 15 pg/microg protein. These IL-6 values significantly correlated with the degree of redundancy (P < or = .03). The degree of degenerative change (chondromalacia, fibrillation), disc displacement (roofing), and the presence or absence of adhesions did not significantly affect the levels of IL-6 within the patients studied. The presence of IL-1 beta and TNF-alpha was not found to correlate with the arthroscopic findings in the superior joint space. CONCLUSIONS: The presence of IL-6 correlated with the degree of acute synovitis. IL-1 beta and TNF-alpha were not found in significant levels within the superior joint space. These findings correlated with those reported by other investigators. The production of IL-6 by synovial cells and its role in TMJ disease warrants further investigation.


Assuntos
Artroscopia , Citocinas/análise , Mediadores da Inflamação/análise , Síndrome da Disfunção da Articulação Temporomandibular/imunologia , Adolescente , Adulto , Idoso , Artroscopia/métodos , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Interleucina-1/análise , Interleucina-6/análise , Masculino , Pessoa de Meia-Idade , Líquido Sinovial/química , Articulação Temporomandibular/imunologia , Síndrome da Disfunção da Articulação Temporomandibular/cirurgia , Fator de Necrose Tumoral alfa/análise
5.
J Hist Dent ; 44(3): 105-9, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9468900

RESUMO

The development of hospital dentistry in America began in the middle of the nineteenth century with the pioneering endeavors of Dr. Simon Hullihen and Dr. James Garretson who is credited with the development of the specialty of oral surgery. While starting small, the prodigious work of these and other dentists laid the foundation on which modern hospital dentistry would be built. Throughout its establishment, however, hospital dentistry would have to fight for a place in the hospital, not only with the medical community but also from within the dental community. In time though, hospital dentistry would come to have the support of the American Dental Association and the respect of the medical community.


Assuntos
Unidade Hospitalar de Odontologia/história , Acreditação/história , American Dental Association/história , Equipe Hospitalar de Odontologia/história , História do Século XIX , História do Século XX , Cirurgia Bucal/história , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...